机构地区:[1]西南医科大学附属口腔医院儿童口腔科,四川泸州646000 [2]西南医科大学口腔医学院,四川泸州646000 [3]西南医科大学口颌面修复重建和再生泸州市重点实验室,四川泸州646000 [4]西南医科大学附属口腔医院牙周黏膜病科,四川泸州646000
出 处:《口腔疾病防治》2025年第2期160-168,共9页Journal of Prevention and Treatment for Stomatological Diseases
基 金:四川省科技厅重点研发项目(2022YFS0634);四川省医学青年创新课题计划(Q23028)。
摘 要:口腔鳞状细胞癌(oral squamous cell carcinoma,OSCC)是头颈部最常见的恶性肿瘤,其强侵袭性、高淋巴结转移的特点是患者预后差的主要原因。肿瘤微环境(tumor microenvironment,TME)是肿瘤细胞生存的特殊微环境。肿瘤相关免疫细胞(tumor-associated immune cell,TAIC)是TME主要的基质细胞。一方面,TAIC调控与OSCC相关的增殖、侵袭、上皮-间充质转化(epithelial mesenchymal transformation,EMT)和抗肿瘤免疫。肿瘤相关巨噬细胞(tumor-associated macrophages,TAMs)中的促肿瘤型M2-TAMs通过MIF/NLRP3/IL-1β分子轴促进OSCC的侵袭转移;肿瘤相关中性粒细胞(tumor-associated neutrophils,TANs)中的促肿瘤型N2-TANs通过JAK2/STAT3通路促进OSCC细胞的增殖和EMT;髓源性抑制细胞(myeloid-derived suppressor cells,MDSCs)分泌白细胞介素(interleukin,IL)-6、IL-10和转化生长因子(transforming growth factor,TGF)-β促进OSCC进展;而T淋巴细胞可分泌IL-17促进炎症进展,也可分泌IL-10和TGF-β抑制炎症介导的肿瘤免疫反应;自然杀伤(natural killer,NK)细胞识别并攻击肿瘤细胞进而抑制OSCC的进展。另一方面,TAIC之间的相互作用也调控OSCC的进展。M2-TAMs分泌IL-10和程序性死亡配体(programmed death-ligand,PD-L)-1促进T淋巴细胞的凋亡调控OSCC的侵袭转移;N2-TANs分泌血凝素样氧化低密度脂蛋白受体-1和精氨酸酶-1抑制T淋巴细胞的增殖和细胞毒性;MDSCs通过抑制程序性细胞死亡受体(programmed cell death,PD)-1/PD-L1信号传导抑制CD8+T淋巴细胞的增殖和抗肿瘤效应;同时,MDSCs也可降低CD3-zeta链的表达和干扰素-γ(interferon-γ,IFN-γ)的分泌抑制T淋巴细胞增殖;而肿瘤浸润淋巴细胞(tumor-infiltrating lymphocytes,TILs)与NK细胞的数量在OSCC进展中呈正相关关系。因此,靶向调控OSCC中TAIC及其相关的信号通路,精准靶向TAIC之间的相互作用将有望提高免疫治疗疗效从而抑制OSCC进展。笔者对近年来TME中TAIC及其相互作用对OOral squamous cell carcinoma(OSCC),the most common type of head and neck malignancy,has a poor prognosis owing to its high invasiveness and high rate of cervical lymph node metastasis.The tumor microenvironment(TME)is a complex microenvironment that is essential for tumor cell survival.Tumor-associated immune cell(TAIC),the main stromal cell of TME,regulates the proliferation,invasion,epithelial-mesenchymal transformation(EMT),and anti-tumor immunity of OSCC.M2-tumor-associated macrophages(TAMs)promote the invasion and metastasis of OSCC through the macrophage migration inhibitory factor/NOD-like receptor family pyrin domain containing 3/interleukin(IL)-1βaxis,while N2-tumor-associated neutrophils(TANs)regulate the proliferation and EMT of OSCC through the Janus kinase 2/signal transducer and activator of transcription 3 pathway.Meanwhile,myeloid-derived suppressor cells(MDSCs)accel-erate the progression of OSCC by secreting IL-6,IL-10,and transforming growth factor(TGF)-β;T cells promote inflam-mation by secreting IL-17 and inhibit inflammation-mediated tumor immune response by secreting IL-10 and TGF-β;and natural killer(NK)cells recognize and attack OSCC cells to inhibit OSCC progression.TAIC interaction network al-so regulates OSCC progression.M2-TAMs regulate the invasion and metastasis of OSCC by promoting T cell apoptosis through the secretion of IL-10 and programmed death-ligand(PD-L)-1,while N2-TANs inhibit T cell proliferation and cytotoxicity by secreting LOX-1 and arginase-1.MDSCs inhibit the proliferation and anti-tumor effects of CD8+T cells through the inactivation of programmed cell death(PD)-1/PD-L1 signaling.Additionally,MDSCs inhibit the proliferation of T cells by decreasing the expression of the CD3-zeta chain and interferon-γ(IFN-γ).Moreover,tumor-infiltrating lym-phocytes and NK cells were found to be positively correlated in OSCC progression.Therefore,target regulation,related signaling pathways,and the interaction network of TAIC may serve as promising therapeutic targets in the immu
关 键 词:肿瘤微环境 肿瘤相关免疫细胞 肿瘤相关巨噬细胞 肿瘤相关中性粒细胞 髓源性抑制细胞 T淋巴细胞 自然杀伤细胞 口腔鳞状细胞癌 基质细胞 肿瘤免疫
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...